Castle Biosciences Stock Price To Book

CSTL Stock  USD 27.09  0.57  2.15%   
Castle Biosciences fundamentals help investors to digest information that contributes to Castle Biosciences' financial success or failures. It also enables traders to predict the movement of Castle Stock. The fundamental analysis module provides a way to measure Castle Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Castle Biosciences stock.
Price To Book Ratio is expected to rise to 1.55 this year.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Castle Biosciences Company Price To Book Analysis

Castle Biosciences' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

P/B

 = 

MV Per Share

BV Per Share

More About Price To Book | All Equity Analysis

Current Castle Biosciences Price To Book

    
  1.68 X  
Most of Castle Biosciences' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Castle Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Castle Price To Book Driver Correlations

Understanding the fundamental principles of building solid financial models for Castle Biosciences is extremely important. It helps to project a fair market value of Castle Stock properly, considering its historical fundamentals such as Price To Book. Since Castle Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Castle Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Castle Biosciences' interrelated accounts and indicators.
1.00.980.81-0.82-0.720.640.420.820.420.910.791.00.90.980.970.640.930.970.82-0.91
1.00.990.8-0.84-0.70.630.410.80.410.90.761.00.90.980.980.650.920.970.8-0.91
0.980.990.8-0.89-0.630.570.380.760.380.90.690.990.91.00.990.730.920.960.73-0.92
0.810.80.8-0.63-0.680.670.80.830.80.890.770.810.840.810.790.640.850.850.73-0.88
-0.82-0.84-0.89-0.630.25-0.22-0.19-0.42-0.19-0.72-0.37-0.84-0.71-0.91-0.93-0.71-0.72-0.76-0.390.76
-0.72-0.7-0.63-0.680.25-0.97-0.59-0.88-0.59-0.74-0.86-0.7-0.75-0.61-0.58-0.28-0.69-0.74-0.980.68
0.640.630.570.67-0.22-0.970.630.830.630.730.780.630.730.560.530.30.620.690.93-0.66
0.420.410.380.8-0.19-0.590.630.661.00.490.60.40.420.390.370.150.410.450.55-0.45
0.820.80.760.83-0.42-0.880.830.660.660.830.940.810.810.730.70.440.850.880.87-0.8
0.420.410.380.8-0.19-0.590.631.00.660.490.60.40.420.390.370.150.410.450.55-0.45
0.910.90.90.89-0.72-0.740.730.490.830.490.780.921.00.90.890.80.970.960.81-0.99
0.790.760.690.77-0.37-0.860.780.60.940.60.780.770.760.670.630.30.790.820.88-0.76
1.01.00.990.81-0.84-0.70.630.40.810.40.920.770.910.990.980.680.940.980.8-0.93
0.90.90.90.84-0.71-0.750.730.420.810.421.00.760.910.890.880.810.960.960.81-0.99
0.980.981.00.81-0.91-0.610.560.390.730.390.90.670.990.891.00.720.910.950.72-0.91
0.970.980.990.79-0.93-0.580.530.370.70.370.890.630.980.881.00.730.890.930.69-0.9
0.640.650.730.64-0.71-0.280.30.150.440.150.80.30.680.810.720.730.80.730.36-0.83
0.930.920.920.85-0.72-0.690.620.410.850.410.970.790.940.960.910.890.80.980.77-0.98
0.970.970.960.85-0.76-0.740.690.450.880.450.960.820.980.960.950.930.730.980.82-0.97
0.820.80.730.73-0.39-0.980.930.550.870.550.810.880.80.810.720.690.360.770.82-0.77
-0.91-0.91-0.92-0.880.760.68-0.66-0.45-0.8-0.45-0.99-0.76-0.93-0.99-0.91-0.9-0.83-0.98-0.97-0.77
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Competition

Castle Book Value Per Share

Book Value Per Share

8.66

At this time, Castle Biosciences' Book Value Per Share is quite stable compared to the past year.
Based on the latest financial disclosure, Castle Biosciences has a Price To Book of 1.6834 times. This is 93.44% lower than that of the Biotechnology sector and 77.85% lower than that of the Health Care industry. The price to book for all United States stocks is 82.3% higher than that of the company.

Castle Price To Book Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Castle Biosciences' direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Castle Biosciences could also be used in its relative valuation, which is a method of valuing Castle Biosciences by comparing valuation metrics of similar companies.
Castle Biosciences is currently under evaluation in price to book category among its peers.

Castle Biosciences ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Castle Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Castle Biosciences' managers, analysts, and investors.
Environmental
Governance
Social

Castle Fundamentals

About Castle Biosciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Castle Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Castle Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Castle Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Castle Biosciences is a strong investment it is important to analyze Castle Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Castle Biosciences' future performance. For an informed investment choice regarding Castle Stock, refer to the following important reports:
Check out Castle Biosciences Piotroski F Score and Castle Biosciences Altman Z Score analysis.
For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.93)
Earnings Share
0.21
Revenue Per Share
11.34
Quarterly Revenue Growth
0.395
Return On Assets
(0)
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.